Search alternatives:
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 means » _ means (Expand Search), k means (Expand Search), i means (Expand Search)
means decrease » mean decrease (Expand Search), deaths decreased (Expand Search)
step decrease » sizes decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
5 means » _ means (Expand Search), k means (Expand Search), i means (Expand Search)
-
61
-
62
-
63
-
64
Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab.
Published 2025Subjects: -
65
-
66
-
67
Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.
Published 2025Subjects: -
68
Baseline patient characteristics across neutralizing monoclonal antibody trials.
Published 2025Subjects: -
69
-
70
-
71
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
Published 2025Subjects: -
72
-
73
-
74
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
Published 2025Subjects: -
75
-
76
-
77
-
78
-
79
-
80